385 related articles for article (PubMed ID: 21605103)
1. On isotretinoin dosing, adverse effects, and efficacy.
Berk DR
Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
[No Abstract] [Full Text] [Related]
2. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
Rademaker M
Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
[TBL] [Abstract][Full Text] [Related]
3. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
Layton AM; Dréno B; Gollnick H; Mobaken H; Shear N
Br J Dermatol; 2009 Jan; 160(1):217-8; author reply 218-9. PubMed ID: 19067687
[No Abstract] [Full Text] [Related]
4. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
[No Abstract] [Full Text] [Related]
5. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
Verros CD; Rallis E
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
[No Abstract] [Full Text] [Related]
6. Night blindness following low-dose isotretinoin.
Halpagi P; Grigg J; Klistorner A; Damian DL
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):893-4. PubMed ID: 18031494
[No Abstract] [Full Text] [Related]
7. Acute myopathy and acne fulminans triggered by isotretinoin therapy.
Sarifakioglu E; Onur O; Kart H; Yilmaz AE
Eur J Dermatol; 2011; 21(5):794-5. PubMed ID: 21727056
[No Abstract] [Full Text] [Related]
8. Low-dose schema of isotretinoin in acne vulgaris.
Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
Kaymak Y; Ilter N
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
[TBL] [Abstract][Full Text] [Related]
11. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin: stroke and myocardial infarction?
Prescrire Int; 2007 Jun; 16(89):113. PubMed ID: 17590908
[No Abstract] [Full Text] [Related]
13. Isotretinoin updates.
On SC; Zeichner J
Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
[TBL] [Abstract][Full Text] [Related]
14. Oral isotretinoin for acne, adjusting treatment according to patient's response.
Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
Boyraz N; Mustak PK
Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
[TBL] [Abstract][Full Text] [Related]
16. Retrospective case series of isotretinoin outcomes for acne in 393 female patients at Baylor College of Medicine during 2012-2016.
Fernandez J; Lee B; Patel JM; Weiss E; Jiang J; Dao H; Kim SJ
J Am Acad Dermatol; 2020 May; 82(5):1218-1219. PubMed ID: 31443910
[No Abstract] [Full Text] [Related]
17. Isotretinoin-induced elkonyxis.
Yung A; Johnson P; Goodfield MJ
Br J Dermatol; 2005 Sep; 153(3):671-2. PubMed ID: 16120167
[No Abstract] [Full Text] [Related]
18. The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.
Rigopoulos D; Larios G; Katsambas AD
Clin Dermatol; 2010; 28(1):24-30. PubMed ID: 20082946
[TBL] [Abstract][Full Text] [Related]
19. Acne fulminans following isotretinoin therapy.
Didona D; Paolino G; Cantisani C; Viti G; Caposiena Caro DR; Didona B
G Ital Dermatol Venereol; 2019 Feb; 154(1):84-85. PubMed ID: 28712269
[No Abstract] [Full Text] [Related]
20. Isotretinoin dosing: past, present, and future trends.
Hirsch RJ; Shalita AR
Semin Cutan Med Surg; 2001 Sep; 20(3):162-5. PubMed ID: 11594671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]